Insider Sale by Chin Peter Scott (Chief Medical Officer)
Trade Summary
6 days ago, Chin Peter Scott, serving as Chief Medical Officer at Denali Therapeutics Inc. (DNLI), sold 1,654 shares at $22.29 per share, for a total transaction value of $36,867.66. Following this transaction, Chin Peter Scott now holds 204,538 shares of DNLI.
This sale represents a 0.80% decrease in Chin Peter Scott's stake in the company.
The trade was executed on Friday, September 4, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, September 9, 2026 at 4:44 PM ET, 5 days after the trade was made.
Denali Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$22.29
Quantity
1,654
Total Value
$36,867.66
Shares Owned
204,538
Trade Date
6 days ago
SEC Filing Date
at 4:44 PM ET
Filed 5 days after trade
Discussion